Curriculum vitae laurie k. Mccauley



Download 408.59 Kb.
Page4/7
Date conversion16.11.2016
Size408.59 Kb.
1   2   3   4   5   6   7

Michigan Center for Oral Health Research School-wide Meeting, Ann Arbor, MI, May 4, 2004. “Impact of parathyroid hormone on osseous regeneration in the oral cavity.”

National Institutes of Health, National Institute for Dental and Craniofacial Research, Intramural Research Program, Washington DC, May 13, 2004. “Emerging roles for PTH in bone regeneration and skeletal metastasis.”


Advances in Skeletal Anabolic Agents and the Treatment of Osteoporosis. Session II: Skeletal Anabolism: Transcriptional Regulation and Signalling, American Society for Bone and Mineral Research (ASBMR) and National Institutes of Health (NIH), Washington DC, May 24, 2004. “Anabolic Actions of PTH in bone: Role of AP-1 and Osteoclastogenesis.”
University of Michigan, Bone Center CCR Seminar Series, Ann Arbor, MI, June 2, 2004. “Actions of parathyroid hormones in bone: from signaling pathways in vitro to new cellular targets in vivo.”
Conference Workshop on Strategic Research to Enable NASA’s Exploration Missions, Cleveland, OH, June 23, 2004. “Pulsed PTH to counter bone loss.”
Thai Perio Society Meeting, Bangkok, Thailand, August 5, 2004. “Metabolic bone diseases and their impact in the oral cavity.”
Chiang Mei University, Chiang Mei, Thailand, August 7, 2004. “Parathyroid hormones, tooth eruption, cementum, and root resorption”.
Prout’s Neck Meeting on Prostate Cancer, Prout’s Neck Maine, November 6th, 2004. “The Bone Marrow Microenvironment and Prostate Cancer Localization.”
Unit for Lab Animal Medicine, University of Michigan, December 9th, 2004. “PTH: Friend or Foe?”
Endocrine Conference, Emory University, Atlanta, GA, January 10, 2005. “Anabolic Actions of Parathyroid Hormone in Bone: Beyond Osteoblasts.”
Michigan Difference Seminars, Naples and Palm Beach, FL, February 21-22, 2005. “Keeping Your Bones Strong.”
University of Michigan NASA Biomedical Engineering Institute, March 28, 2005. "Local Delivery of Parathyroid Hormone Counter Balances Microgravity-Associated bone Loss.”
Department of Biomedical Engineering Seminar Series, University of Michigan, April 4, 2005. “Anabolic Actions of Parathyroid Hormones: Engineering Models to Elucidate Mechanisms of Action in Bone"
Paget’s Foundation, Skeletal Complications of Metastasis Meeting, Invited Speaker. NIH Campus, April 28, 2005 “The Bone Marrow Microenvironment: Modulation by Parathyroid Hormones and Support of Prostate Cancer Localization”
Center for Metabolic Bone Disease, University of Alabama, Birmingham, AL, May 19, 2005 “Anabolic Actions of parathyroid Hormone in Bone: Role of Cells in the Bone Marrow Microenvironment”
Ecole Normale Superior (ENS), Lyon France, June 16, 2005 “Anabolic Activities of Parathyroid Hormones in Bone: Osteoclasts Make the Difference.”
University Lyon-1, UFR d’Odontologie, Lyon France, January 26, 2006 “Parathyroid hormones: Profiles of action in cementum and bone”.
Faculté de Médecine Laënnec, Lyon France February 16, 2006 “The Bone Marrow Microenvironment: Modulation by Parathryoid Hormones and Support of Prostate Cancer Localization”
Hôpital Lariboisière Paris France, March 31, 2006 “Anabolic actions of PTH: New insights into cellular targets in bone”.
Les 9èmes Journées Françaises de Biologie des Tissus Minéralisés: Conférence Plénière (plenary speaker), "Anabolic actions of parathyroid hormones in bone: New paradigms and cellular targets”. Lyon France, May 19, 2006.
Yonsei University, Seoul, Korea, July 6, 2006. “Roles and Mechanisms of Action of Parathyroid Hormones in Cementum and Bone”.
American Society for Bone and Mineral Research (ASBMR) Invited symposium speaker for ‘Osteoclast Signaling and Function’ Symposium, Philadelphia, Pennsylvania, September 17, 2006. “PTH and Osteoclasts: Changing Roles in Bone Remodeling and Regeneration”
University of Connecticut Health Center, School of Medicine, October 24, 2006. “Models and Mechanisms for Parathyroid Hormone Action in Bone Regeneration”
Oral Health Sciences PhD Program Seminar Series, University of Michigan, February 1, 2007. “Parathyroid hormone targets multiple cellular circuits for skeletal anabolism”
The 7th Biennial Sigurd Ramfjord Symposium, University of Michigan, April 21, 2007. “Metabolic Bone Diseases and their Impact in the Oral Cavity”.
Combined Program Project Meeting – Emory, Univ. Washington, Univ. Michigan, March 29th, 2007, Ann Arbor Michigan. “The bone marrow microenvironment and hematopoietic stem cell interactions with prostate cancer”.
University of Michigan, School of Dentistry, Continuing Education, June 22, 2007. “Medical History: Metabolic Bone Disease”
Sun Valley Workshop on Skeletal Biology (invited speaker), August 8, 2007. “Distinguishing Features of the Oral Cavity and its Pre-disposition to ONJ”
Wyeth Research, Collegeville, PA. October 4, 2007. “Anabolic actions of parathyroid hormones in bone: Models and mechanisms for regenerative medicine”.
The Paget’s Foundation Skeletal Complications of Malignancy Meeting, October 27, 2007, Philadelphia, PA. “Pathophysiology of Osteonecrosis of the Jaw”.
The 9th International Conference on the Chemistry and Biology of Mineralized Tissues. November 06, 2007, Austin Texas. “Osteonecrosis of the Jaw: An Update and Report of the ASBMR Task Force”
University of Michigan, Organogenesis Center, November 29, 2007. “Mechanisms of Parathyroid Hormone Action in Skeletal Regenerative Biology”
University of Michigan, Orthopedic Research Laboratories, January 15, 2008. “The Bone Marrow Microenvironment: Modulation by Parathyroid Hormones and Support of Prostate Cancer Metastasis”
Combined Program Project Meeting – Emory, Univ. Washington, Univ. Michigan, February 6th, 2008, Stone Mountain Georgia. “The role of PTHrP in the bone metastatic microenvironment of prostate cancer”.
University of Michigan, Moyer's Presymposium, February 29, 2008. “The Impact of Bisphosphonates on Craniofacial Bone and Tooth Movement”
University of Alabama, Center for Metabolic Bone Disease Symposium, Birmingham, AL, March 26, 2008, “Cell systems and targets of PTH action in bone”.
American Association for Dental Research (AADR) Symposium on Osteonecrosis of the Jaw, Dallas, Texas, April 3, 2008. “Osteonecrosis: Why the Jaw?”
Harbin Medical University, Harbin China, April 29, 2008. “Emerging aspects of parathyroid hormone action in bone: Osteoimmunology meets endocrinology”.
Yang Ming University, Taipei Taiwan, May 2, 2008. “Parathyroid hormones and skeletal regeneration: Translational studies linking endocrinology and osteoimmunology”.
The University of Michigan, Department of Radiology, June 5, 2008. “The Bone Marrow Microenvironment: Modulation by Parathyroid Hormones and Support of Prostate Cancer Metastasis”.
American Society for Bone and Mineral Research (ASBMR) Invited symposium speaker for ‘Novel Treatments of Bone Disease’ Symposium, Montreal, Canada, September 12, 2008. “Anabolic Mechanisms of Parathyroid Hormone Action in Bone”
Leeds/Michigan Tissue Engineering Meeting, Leeds, UK October 16th 2008 “Anabolic mechanisms of PTH action during bone regeneration” 
Northwestern University, Department of Molecular Pharmacology and Biological Chemistry, February 2, 2009. “PTHrP and the bone marrow microenvironment in prostate cancer metastasis”
Genesee District Dental Society, April 7, 2009. “Bisphosphonates and their effects on dental treatment”.
11th International Symposium on Basic and Physiopathological Aspects of Parathyroid Hormone (PTH) and PTH-Related Protein, Strasbourg France, July 10,2009. “ Prostate cancer-derived PTHrP and the tumor microenvironment of the skeletal metastatic lesion”

American Society for Bone and Mineral Research (ASBMR) Annual Meeting Denver Colorado, Meet the Professor Sessions, September 11 and 12, 2009. “Osteonecrosis of the Jaw: Problems and Perspectives”.


American Academy of Periodontology Annual Meeting, Boston, MA, September 14, 2009. “Treatment strategies for metabolic bone diseases: impact on clinical practice and applications for periodontal regeneration.” 
Fifth International Conference on Tumor Microenvironment: Progression, Therapy & Prevention, Versaille, France, October 23, 2009. “A novel role for megakaryocytes in the bone marrow microenvironment of prostate cancer metastasis”.
The University of Pennsylvania, Mari Lowe Center for Comparative Oncology Seminar Series, Philadelphia, PA, November 5, 2009. “Prostate Cancer-derived PTHrP and the tumor microenvironment of the skeletal metastatic lesion”.
Eli Lilly and Co. Indianapolis, IN, November 16, 2009. “Teriparatide and Periodontics”
McGill University, Medical School Department of Anatomy and Cell Biology Seminar, December 16, 2009. “Mechanisms of action of parathyroid hormone (PTH) in the bone marrow microenvironment”.
McGill University, School of Dentistry Seminar, December 17, 2009. “Metabolic Bone Disease Therapeutics and Oral Health: From Osteonecrosis of the Jaw to Osseous Regeneration”.
University of Michigan, Department of Pathology, Medical School, January 7, 2010. “An unstable cascade in the bone marrow microenvironment drives prostate cancer skeletal metastasis”.
University of Maryland, School of Dentistry, February 18, 2010. “Tumor interactions in the bone marrow microenvironment of the skeletal metastatic lesion”.
University of Pittsburgh, McGowan Institute Retreat on Regenerative Medicine, March 9, 2010. "Parathyroid hormone: skeletal and craniofacial regeneration"
University of Alabama, Center for Metabolic Bone Disease, March 31, 2010. “Parathyroid hormone: Integrator of hematopoietic cells and bone”
Aegean Conferences: 3rd International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems, June 21, 2010. "Parathyroid hormone: A dynamic regulator of bone, immune, and hematopoietic cells"
University of Michigan Medical School, Camp Peace (summer camp for low-income minorities). "Doctor for a Day" A Career in Dentistry, July 29, 2010.
Institut André Lwoff, Université Paris XI, Hôpital Paul Brousse. January 14, 2011. “Parathyroid hormone drives bone regeneration in partnership with hematopoietic cells”
American Society for Bone and Mineral Research Clinical Update for Health Professionals. September 17, 2011. “A Dental Perspective on Osteoporosis Therapy: New Applications and Long Term Risks”
Washington University, St. Louis, MO, Avioli Seminar. October 7, 2011. “Parathyroid hormone engages niche osteoblasts and hematopoietic cells to drive anabolic actions in bone”.
New York University, College of Dentistry, New York, NY. October 31, 2011. “Anabolic actions of PTH in bone: From the cell and molecular level to a clinical application.”
Korean Society of Bone Metabolism, Seoul, Korea, November 19, 2011. “Crosstalk between bone and the hematopoietic system modulates anabolic actions of parathyroid hormone.”
International Bone and Mineral Society (IBMS) Cancer Induced Bone Disease (CIBD) Conference, Chicago, IL, December 2, 2011. “Bone marrow derived myeloid cells set the stage for prostate cancer skeletal metastasis”.
Brigham and Women’s Hospital, Harvard Institute for Medical Sciences, Boston, MA, January 6, 2012. “Novel mechanisms of parathyroid hormone action link the skeletal and hematopoietic systems”
Yale University, Yale Bone Center, January 19, 2012, “Interleukin-6 signaling links hematopoietic and anabolic actions of PTH in Bone”.
Yale University Endocrine Grand Rounds, January 20, 2012, “Osteoporosis Therapeutics and the Oral Cavity: Impact, Risks, and Prospects”.
University of Michigan Metabolism, Endocrinology, and Diabetes Clinical Conference, January 27, 2012, "Impact of Therapeutics for Metabolic Bone Disease on the Oral Cavity".
Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration, March 18, 2012, Keynote Presentation: “Understanding basic mechanisms fosters a clinical application in craniofacial regeneration”.
Osteoncology Symposium, Tübingen Germany, March 24, 2012, Keynote Presentation: “Translational osteooncology- from bench to bone!”
MICHR Career Development Seminar, University of Michigan, April 10, 2012, “Time management”
Combined Program Project Meeting (Univ. Michigan, Univ. Seattle, UCLA) April 12th, 2012, Ann Arbor, MI. “The microenvironment matters: The bone marrow 'soil' and prostate cancer”.
International Symposium on Osteoporosis (National Osteoporosis Foundation), Orlando Florida April 27, 2012, Plenary symposium ‘Untoward Effects of Osteoporosis Medicine’ Invited speaker: “Osteonecrosis of the Jaw”.
International Association for Dental Research (IADR), Iguassu Falls, Brazil, June 20, 2012, Keynote presentation, “Osteoblasts and Hematopoietic Cells: Parathyroid Hormone Joins Forces to Build Bone”.
Osteology Foundation, Zurich, Switzerland, June 25, 2012, “Cellular mechanisms of Parathyroid Hormone Action Profile the Osseous Wound Healing Potential in Animal Models and Human Patients”.
Gordon Research Conference on Proteoglycans Invited Speaker, July 11, 2012, “The Role of Proteoglycan 4 in Skeletal Development.”
American Society for Bone and Mineral Research (ASBMR) Annual Meeting Minneapolis, MN, Meet the Professor, October 14, 2012. “PTH and the Marrow Microenvironment”.
International Society for Bone Morphometry Minnetonka, MN, Invited Speaker, October 17, 2012. “Dissecting the Role of Myeloid Lineage Cells in Prostate Cancer Skeletal Metastasis”
Harvard School of Dental Medicine (HSDM)/Harvard Medical School (HMS)/Massachusetts General Hospital (MGH) Bone Research Workshop Series, Boston, MA, January 25, 2013. “The Osteomac: An Accomplice to Anabolic Actions of PTH in Bone”


RESEARCH SUPPORT (Principal investigator and select Co-I projects; direct costs/year)

1988-1991

NIH: National Research Service Award (Individual Award) (F32 DE05524) National Institute of Dental Research

Mechanisms of Lymphocyte-Mediated Bone Resorption



Individual Trainee


$38,418





1990-1991

American Fund for Dental Health Dental Teacher Training Award to

Dental Teacher Training Award to pursue pedagogical and research training.



Principal Investigator/Trainee


$20,000




1992-1993

Biomedical Research Support Grant

The Effects of Cyclosporin A on Osteoblasts.



Principal Investigator


$5,000




1992-1993

Geriatrics Center Feasibility Grant (U of M)

Aging and Immunologic Homeostasis: Regulation of Osteopontin Production in T-Lymphocytes



Principal Investigator


$24,050




1993-1994

American Federation for Aging Research (AFAR)

Aging and Parathyroid Hormone (PTH) Function: Effects of Estrogen on PTH Receptors in Bone



Principal Investigator


$22,484




1993-1994

Comprehensive Cancer Ctr., (U of M)

Mechanisms of TGFß1 Regulation of Parathyroid Hormone-Related Protein Receptors on Osteosarcoma Cells



Principal Investigator


$8,700




1993-1994

Sandoz Foundation for Gerontologic Research

Potentials for Treatment of Age-Dependent Bone Loss with Cyclosporin Analogs



Principal Investigator

$20,000




1993-1995

Horace H. Rackham School of Graduate Studies Faculty Grant

Cell Cycle Regulation of the Parathyroid Hormone Receptor on Osteoblasts



Principal Investigator


$14,090




1995

University of Michigan, Career Development Award for Women Faculty

Principal Investigator


$5,000




1995-1997

NSF: (Molecular and Cellular Biosciences)

SBIR Phase II: Diffusion Gradient System for Processes and Behavior in Microbial and Cellular Biology



Subcontract


$5,000




1994-1999

NIH: (National Institute for Diabetes, Digestive, and Kidney Disease)

R29 DK46919

Molecular Regulation of the Parathyroid Hormone Receptor

Principal Investigator


$75,000




1995-1998

NIH: (National Cancer Institute)

SPORE P50 CA69568

PTHrP as an Autocrine Mediator of Bone Metastases Associated with Prostate Cancer

Principal Investigator for Research Career Development Award


$90,804




1997-1999

NIH: (National Institute for Dental Research)

R03 DE12267

Transgenic Cre-lox Model for PTH Receptor Action in Bone

Principal Investigator


$25,000




1997-1998

NIH: (National Institute for Dental Research)

P20 DE12387

Center for Biorestoration of Oral Health

Principal Investigator


$100,000




1998-1999

Office of the Vice President for Research: University of Michigan

Distinguished Faculty and Graduate Student Seminar Series



Principal Investigator


$7,500




1998-2003

NIH: (National Institute for Dental and Craniofacial Research)

RO1 DE60473 (PI - K. Rice)

Regulated Osteoinductive Plasmid Gene Transfer via Gene Activated Matrices

Co-Investigator


$200,000




1998-2003

NIH: (National Institute for Diabetes Digestive, and Kidney Disease)

R01 DK53904-01 $180,577

Anabolic Mechanisms of PTH Action in Bone

Principal Investigator


$138,000




2002

CBER: University of Michigan, Center for Biomedical Engineering Research

Skeletal Systems Engineering



Principal Investigator


$75,000




2001-2002

Comprehensive Cancer Ctr., (U of M)

PTHrP as a Mediator of Osteoblastic Metastases



Principal Investigator


$10,000




2001-2005

Department of Defense

Molecular Mechanisms of Prostate Cancer Metastasis

(PI – R. Taichman)

Co-Investigator


$100,000




2001-2006

NIH: (National Institute for Arthritis and Musculoskeletal and Skin Disease)

Mechanical and Biological Influences on Bone Response: Core Center

P30 AR 46024

Associate Director and Co-Investigator




$400,000




2003

SPORE in Prostate Cancer (seed project of National Cancer Institute Parent project P50 CA69568)

The Role of Bone Turnover in the Predilection of Prostate Cancer Metastasis in Bone



Principal Investigator


$8,700




2003-2008

NIH: National Inst. for Dental and Craniofacial Res.

Tooth Eruption: Role of Dental Follicle and Parathyroid Hormone (PTH) Receptor

RO1 DE014073

Principal Investigator


$194,000




2003-2008

NIH: National Institute for Diabetes Digestive, and Kidney Disease

RO1 DK53904-05

Anabolic Mechanisms of PTH Action in Bone

Principal Investigator


$200,000




2004-2007

NIH: National Institute for Diabetes Digestive and Kidney Disease

RO1 DK053904-06S1

Anabolic Mechanisms of PTH Action in Bone

This is a minority graduate student supplement.




$55,000




2004-2009

NIH:NCI Program Project Award

The Biology of Prostate Cancer Skeletal Metastases

(PI-E. Keller)

Co-Investigator (PI on Project 4 and Core B)


$1,189,870




2003-2006

University of Pittsburgh, Collaborative Research Program

Grant Program Pathogenesis and Treatment of Myeloma Bone Disease

(PI-G. D. Roodman U. of Pittsburgh)

Co-investigator


$500,000




2003-2007

NASA

NASA Biomedical Engineering Institute at Michigan

(PI-J. Grotberg)

Co-Investigator (Theme leader)


$300,000




2005-2009

Eli Lilly and Company

Impact of PTH on osseous regeneration in the oral cavity

(PI- L.McCauley)

Primary Investigator


$32,180




2008-2010

Department of Defense

U.S. Army Medical Research and Materiel Command

Prostate Cancer Training Award

Inhibitory Effect of Megakaryocyte in Prostate Cancer Bone Metastasis

(PI – Xin Li)

Mentor to Xin Li (post-doctoral fellow)


$50,000




2008-2011

Department of Defense

U.S. Army Medical Research and Materiel Command

Idea Development Award

Bone Marrow Microenvironmental Control of Prostate Cancer Skeletal Localization



Principal Investigator

$124,000




2008-2011

2008-2013

2009-2010
2009-2010

2010-2011



National Institutes of Health

R21 DE019395

Integral role of hematopoietic cells in PTH actions in bone

Principal Investigator
National Institutes of Health

RO1 DK053804-10

Anabolic Mechanisms of PTH Action in Bone

Principal Investigator
Ortho Biotech Oncology R&D/ Centocor R&D

Johnson & Johnson Pharmaceuticals

Impact of CCL-2 and IL-6 Blockade on the Vascular Support

of Prostate Cancer Skeletal Metastasis



Principal Investigator
National Institutes of Health

ARRA - American Recovery and Reinvestment Act

Supplement to R21 DE019395

Principal Investigator
National Institutes of Health

F30 DE021298-01

Fellowship: Novince, Chad Michael

Project Title: Proteoglycan-4:A novel protein regulating skeletal actions of parathyroid hormone



Sponsor


$275,000/yr

$212,000/yr

$97,000

$63,700


$33,000/yr




2010-2012

Department of Defense

U.S. Army Medical Research and Materiel Command

Prostate Cancer Training Award

Alternations of the bone marrow microenvironment contribute to prostate cancer skeletal metastasis

(PI – Serk In Park)

Mentor to Serk In Park (post-doctoral fellow)


$62,080/yr




2009-2014

NIH:NCI Program Project Award

P01 CA093900

The Biology of Prostate Cancer Skeletal Metastases

(PI-E. Keller)



Co-Investigator (Principal Investigator on Project 4 and Core B)


$1,200,000/yr




2011-2016

Department of Defense

Biomimetic Delivery of Biomolecules for Craniofacial Bone Regeneration

W81XWH-12-2-0008

Co-Principal Investigator with Peter Ma


$450,000/yr




2012-2017

NIH: NIDCR 1R01DE022327

PTH and Calcium Synergy for Craniofacial Regeneration

Co-Principal Investigator with Peter Ma

$250,000/yr




2012-2013

Fund for Cancer Research

Role of efferocytosis in skeletal metastasis



Principal Investigator

$75,000/yr




2012-2014

NIH:NIDCR R44 DE022493

Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic Like Stem Cells



Co-Principal Investigator with Russell Taichman and Denis Rodgerson

$1,221,854 over 2 years



1   2   3   4   5   6   7


The database is protected by copyright ©dentisty.org 2016
send message

    Main page